The only market access meeting place you'll need to be at this year

Access Europe Summit 2017 will return to Amsterdam on April 25 and 26 2017 for its 3nd annual edition. Featuring 150+ attendees and 30 expert speakers, this event brings together Europe's most senior market access, pricing, reimbursement, HTA, value and HEOR professionals for 2 days of unmissable learning and networking opportunities.

Every year at Europe's no.1 meeting place for market access, pricing, reimbursement & data professionals, delegates learn how to:

  • Accelerate access to the market with an in-depth understanding of innovative pricing and HTA collaborations across Europe
  • Achieve excellence in evidence: engage your key stakeholders with real world data for a long-term patient-centric strategy
  • Partner with patients to maintain and expand market access for the win-win outcomes payers and providers are looking for
  • Reorganise your internal approach break down your functional silos to provide payers with the robust evidence they want and need

2016 Speakers

Supporters and Attendees in 2016

  • AstraZeneca
    Catalan Health Service
  • celgene
    daiichi sankyo
  • novartis
  • teva
  • JAnssen

Our Track-Record of Proven Success

Conferences promise a lot - we know. Below are a few takeaways from the last year's Summit highlighting the valuable insights the attendees took away …

  • call our sessions essential
  • said they will likely return again next year
  • rated the program very well run

What our Delegates are saying

  • Bayer

    "This was one of the most relevant and comprehensive conferences, which I have attended in recent years. The speakers and meeting chairs were well selected."

    - Karel Mechelse, Market Access Strategy Leader, Bayer
  • Novartis

    "Well worth investing in... a place to exchange views and perspectives"

    - Frederic de Reydet, Global Market Access Director, Novartis
  • Eli-Lilly

    "An excellent representation of key European decision makers"

    - Myriam Zylberman, Senior Director - EU Payer Strategy, Eli Lilly
  • Janssen

    "A fascinating meeting of diverse speakers who outlined numerous themes around the need to prove the validity and trustworthiness of RWE, versus RCTs, with an emphasis on “real time” versus “real world”. Thank you eyeforpharma!"

    - Nigel Hughes, Global Director Marketing/ Health Information Technology Strategy Leader, Janssen

Got a question? Get in touch below!

Connie Thorn

Connie Thorn

Global Project Director
+1800 814 3459 x7535 (US)
+44 (0) 207 375 7535 (Global)

2017 Sponsors & Exhibitors

Gold Sponsor

  • Covance

Silver Sponsor

  • IGES
Don't Miss Out...
Reserve Your Pass Now!